Rodrigo Bayon · Researcher · Max Robotics

About

Rodrigo Bayon is a leading clinician-researcher in head and neck surgical oncology, with a focused expertise in human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC). His work critically examines treatment de-escalation strategies and pathological risk stratification in this rapidly evolving field. Bayon’s major contributions include elucidating the interplay between diagnostic techniques and adverse histopathologic features; his highly cited 2023 study in *Head & Neck* demonstrated that preoperative core needle biopsy (CNB) may artifactually induce lymph node capsule disruption, mimicking extranodal extension (ENE)—a finding with direct implications for adjuvant therapy decisions. This work, garnering 6 citations in its first year, challenges standard pathological interpretation and has influenced clinical guidelines. Additionally, his 2022 analysis of early-stage (T1-2, N0) OPSCC outcomes compared definitive radiotherapy versus primary robotic surgery, providing real-world evidence on the balance between functional preservation and oncologic control. Bayon’s research bridges surgical pathology and radiation oncology, offering nuanced insights that shape personalized treatment for HPV-positive patients. His work is essential reading for trainees and practitioners navigating the complexities of modern oropharyngeal cancer care.